Results 111 to 120 of about 370 (219)

Enhancing translational research in metastatic cancer through an open science environment: the UPTIDER experience. [PDF]

NPJ Precis Oncol
Pabba A, Maetens M, Mahdami A, Geukens T, De Schepper M, Zels G, Van Baelen K, Leduc S, Nguyen HL, Van Cauwenberge J, Borremans K, Hatse S, Nysen M, Rousseau E, Di Tommaso A, Boeckx B, Neven P, Wildiers H, Biganzoli E, Vermeulen P, Van Den Bogaert W, Lambrechts D, Floris G, Desmedt C, Richard F.   +24 more
europepmc   +1 more source

Discovery and 3D imaging of a novel ΔNp63-expressing basal cell type in human pancreatic ducts with implications in disease. [PDF]

Gut, 2021
Martens S, Coolens K, Van Bulck M, Arsenijevic T, Casamitjana J, Fernandez Ruiz A, El Kaoutari A, Martinez de Villareal J, Madhloum H, Esni F, Heremans Y, Leuckx G, Heimberg H, Bouwens L, Jacquemin P, De Paep DL, In't Veld P, D'Haene N, Bouchart C, Dusetti N, Van Laethem JL, Waelput W, Lefesvre P, Real FX, Rovira M, Rooman I.   +25 more
europepmc   +1 more source

The Potential Role of Synovial T Cell Infiltration Following Knee Joint Injury in Symptoms and Progression to Osteoarthritis

Arthritis &Rheumatology, EarlyView.
Objective Identification of osteoarthritis (OA)–specific synovial inflammatory pathways and their temporal relevance is critical for therapeutic targeting. We compared mononuclear inflammatory/immune cell responses following joint injury that does or does not lead to OA to define bona fide OA‐associated cellular events.
Babak Moradi, Miriam T. Jackson, Cindy C. Shu, Susan M. Smith, Margaret M. Smith, Sanaa Zaki, Hadrian Platzer, Nils Rosshirt, David Giangreco, Carla R. Scanzello, Christopher B. Little   +10 more
wiley   +1 more source

Material Preparation Information File (MPIF): A Community-Driven Standard for Reporting MOF Syntheses. [PDF]

Adv Mater
Cheung O, Tokuda S, Jędrzejowski D, Ploetz E, Baumgartner B, Pander M, Yang F, Evans JD, Ettlinger R, Wuttke S, Matoga D.   +10 more
europepmc   +1 more source

Noncoding mutations cause super-enhancer retargeting resulting in protein synthesis dysregulation during B cell lymphoma progression. [PDF]

Nat Genet, 2023
Leeman-Neill RJ, Song D, Bizarro J, Wacheul L, Rothschild G, Singh S, Yang Y, Sarode AY, Gollapalli K, Wu L, Zhang W, Chen Y, Lauring MC, Whisenant DE, Bhavsar S, Lim J, Swerdlow SH, Bhagat G, Zhao Q, Berchowitz LE, Lafontaine DLJ, Wang J, Basu U.   +22 more
europepmc   +1 more source

Tractament arxivístic, explotació i modelatge de dades d'un fons patrimonial de base agrària. Cas d'estudi: El fons patrimonial del mas de Cal Gotzo de Baix, de Clariana (Argençola) [PDF]

Aquest treball estudia el tractament arxivístic del fons patrimonial del mas de Cal Gotzo de Baix (Argençola) amb l'objectiu de garantir-ne l'organització, l'accés i la valoració.
Universitat Autònoma de Barcelona. Escola Superior d'Arxivística i Gestió de Documents, Ribé Seuba, Meritxell   +1 more
core  

Sleep‐trackers in the wild: A faceted taxonomy for information and interaction design

Journal of the Association for Information Science and Technology, EarlyView.
Abstract Consumer‐grade sleep‐tracking technologies (CSTs) have brought sleep into everyday data practices, reframing it from a clinical concern into a site of personal optimization and reflection. Yet existing taxonomies of sleep‐tracking often medicalize users and overlook the complexity of sleep‐tracking technologies. This paper presents SleepTax, a
Sanonda Datta Gupta, Jaime Snyder, John S. Seberger   +2 more
wiley   +1 more source

Complex temporal dynamics of phage-bacteria populations in an animal-associated marine system. [PDF]

Nat Commun
Liang J, Cahier K, Piel D, Cueva Granda D, Goudenège D, Labreuche Y, Ma L, Monot M, Bernard C, Rocha EPC, Le Roux F.   +10 more
europepmc   +1 more source

Data and Tools Integration in the Canadian Open Neuroscience Platform. [PDF]

Sci Data, 2023
Poline JB, Das S, Glatard T, Madjar C, Dickie EW, Lecours X, Beaudry T, Beck N, Behan B, Brown ST, Bujold D, Beauvais M, Caron B, Czech C, Dharsee M, Dugré M, Evans K, Gee T, Ippoliti G, Kiar G, Knoppers BM, Kuehn T, Le D, Lo D, Mazaheri M, MacFarlane D, Muja N, O'Brien EA, O'Callaghan L, Paiva S, Park P, Quesnel D, Rabelais H, Rioux P, Legault M, Tremblay-Mercier J, Rotenberg D, Stone J, Strauss T, Zaytseva K, Zhou J, Duchesne S, Khan AR, Hill S, Evans AC.   +44 more
europepmc   +1 more source

Population pharmacokinetic/pharmacodynamic modelling to evaluate favipiravir in combination with lopinavir–ritonavir in patients with COVID‐19

British Journal of Clinical Pharmacology, EarlyView.
Aims The repurposed use of favipiravir in COVID‐19 has been reported to have limited clinical efficacy, yet it has been widely used in some countries. Favipiravir causes mutagenesis in RNA viruses, and it is currently unknown whether it may have a measurable effect on the virus in humans.
Akosua A. Agyeman, Laura Buggiotti, Li‐An K. Brown, Jose A. Guerra‐Assuncao, Japhette E. Kembou‐Ringert, Wen Y. Mak, Judith Breuer, David M. Lowe, Joseph F. Standing, FLARE Investigators   +9 more
wiley   +1 more source